Skip Over Navigation Links
National Institutes of Health
:
Find more NIMH pages about: Clinical Research and Trials

Science News about Clinical Research And Trials

Find Press Releases and Science Updates by Topic

Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia
September 15, 2008 • Press Release
Two newer atypical antipsychotic medications were no more effective than an older conventional antipsychotic in treating child and adolescent schizophrenia and may lead to more metabolic side effects.
Family-Focused Therapy Effective in Treating Depressive Episodes of Bipolar Youth
September 1, 2008 • Science Update
Adolescents with bipolar disorder who received a nine-month course of family-focused therapy (FFT) recovered more quickly from depressive episodes and stayed free of depression for longer periods than a control group.
New Research to Refine Approaches in Psychotherapy
August 29, 2008 • Science Update
NIMH is funding eight new projects designed to evaluate, refine and improve psychotherapy-based treatments.
Antipsychotic Does Not Harm—and May Improve—Cognitive Skills in Children with Autism
August 27, 2008 • Science Update
The atypical antipsychotic medication risperidone (Risperdal) does not negatively affect cognitive skills of children with autism, and may lead to improvements.
Health Risks Associated with Certain Antipsychotics Warrant Extra Monitoring
July 24, 2008 • Science Update
Some atypical antipsychotics may be more likely than others to cause metabolic and cardiovascular side effects, according to recent analyses using data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
Age-related Decline of ADHD Symptoms Disrupted by Middle School
July 21, 2008 • Science Update
Although symptoms of attention deficit/hyperactivity (ADHD) can last into adulthood, typically they decline as a child gets older.
Newer Antipsychotics No Better Than Older Medications in Reducing Schizophrenia-related Violence
July 11, 2008 • Science Update
Antipsychotic medications can reduce the risk of violence among people with schizophrenia, but the newer atypical antipsychotics are no more effective in doing so than older medications.
Antipsychotic Medications May Ease Some Alzheimer’s Symptoms, Not Others
June 23, 2008 • Science Update
Antipsychotic medications may lessen symptoms like hostility and aggression in patients with Alzheimer’s disease, but do not appear to lessen other symptoms or improve quality of life, according to a recent analysis of data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer’s Disease (CATIE-AD) study. The analysis was published online ahead of print June 2, 2008, in the American Journal of Psychiatry.
New Grant Aims to Overcome Obesity in People with Serious Mental Illness
June 20, 2008 • Science Update
A new grant funded by NIMH will test the effectiveness of a promising intervention designed to help people with serious mental illness (SMI) who are overweight or obese lose weight and keep it off.
HIV-positive Survivors of Sexual Abuse Who Receive Coping Intervention Less Likely to Engage in Unprotected Sex
May 23, 2008 • Science Update
HIV-positive people who have experienced childhood sexual abuse are less likely to engage in risky sexual behavior if they receive a group intervention designed to help them cope with their traumatic history, according to an NIMH-funded study.
1 | 2 | 3 | 4 | 5 | 6 | 7 | Next >